4k1l: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 4k1l is ON HOLD | The entry 4k1l is ON HOLD until Apr 05 2015 | ||
Authors: Loenze, P., Schimanski-Breves, S., Von der Heyden, C., Engel, C.K. | Authors: Loenze, P., Schimanski-Breves, S., Von der Heyden, C., Engel, C.K. | ||
Description: 4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 beta-HSD1 inhibitors for the treatment of diabetes | Description: 4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 beta-HSD1 inhibitors for the treatment of diabetes | ||
Revision as of 12:17, 24 July 2013
Unreleased structure
The entry 4k1l is ON HOLD until Apr 05 2015
Authors: Loenze, P., Schimanski-Breves, S., Von der Heyden, C., Engel, C.K.
Description: 4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 beta-HSD1 inhibitors for the treatment of diabetes
